David E Liddle's Net Worth

$1.45 Billion

Estimate Recalculated Feb 23, 2024 05:50PM EST

Who is David E Liddle?

David E Liddle has an estimated net worth of $1.45 Billion. This is based on reported shares across multiple companies, which include LEADIS TECHNOLOGY INC, OCCAM NETWORKS INC/DE, Altus Pharmaceuticals Inc., NEW YORK TIMES CO, IMPERVA INC, Guidewire Software, Inc., Inspire Medical Systems, Inc., Intersect ENT, Inc., AtriCure, Inc., MAXLINEAR INC, BOX INC, OncoMed Pharmaceuticals Inc, INPHI Corp, INTERMOLECULAR INC, and @ROAD, INC.

SEC CIK

David E Liddle's CIK is 0001212726

Past Insider Trading and Trends

2011 was David E Liddle's most active year for acquiring shares with 22 total transactions. David E Liddle's most active month to acquire stocks was the month of October. 2012 was David E Liddle's most active year for disposing of shares, totalling 48 transactions. David E Liddle's most active month to dispose stocks was the month of October. 2003 saw David E Liddle paying a total of $10,000,000.00 for 1,000,000 shares, this is the most they've acquired in one year. In 2012 David E Liddle cashed out on 21,906,458 shares for a total of $98,431,979.17, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

LEADIS TECHNOLOGY INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-33.31%
-1.01M
2.02M
Jul 26
Form 4
-24.99%
-1.01M
3.02M
May 25
Form 4
-19.99%
-1.00M
4M
Feb 1
Form 4
5.11M
5.11M
Jun 21
Form 3/A
0
0
Form 3
0
0
No matching records found

OCCAM NETWORKS INC/DE No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.18M
0
Feb 22
Form 4
-100.00%
-2.60K
$4.18
-$10,868.00
0
Dec 4
Form 4
-17.80%
-755.22K
$14.32
-$3,952.32
3.49M
Feb 21
Form 4
-7.52%
-309.03K
$13.23
-$4,088,480.13
3.8M
Nov 14
Form 4
+124.57%
2.28M
$13.23
-$8,176,947.03
4.11M
Nov 7
Form 4
0
0
Mar 23
Form 4
0
0
Mar 31
Form 4
0
0
Jan 7
Form 4
0
0
Nov 19
Form 4
0
0
No matching records found

Altus Pharmaceuticals Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-9.96%
-300.00K
$0.32
-$97,290.00
2.71M
Sep 14
Form 4
3.01M
3.01M
Jan 31
Form 3
0
0
No matching records found

NEW YORK TIMES CO (NYT) Snapshot price: $44.935

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 6
Form 4
-100.00%
-2.60K
$12.84
-$33,383.48
0
Nov 4
Form 4
0
0
Apr 30
Form 4
0
0
May 1
Form 4
0
0
Apr 25
Form 4
0
0
Apr 27
Form 4
0
0
Apr 27
Form 4
0
0
Apr 23
Form 4
0
0
Apr 22
Form 4
0
0
Apr 24
Form 4
0
0
Apr 18
Form 4
0
0
Apr 26
Form 4
0
0
Apr 13
No matching records found

IMPERVA INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1,290.11%
1.97M
2.13M
Nov 15
Form 4
152.92K
$18.00
$2,752,542.00
152.92K
Nov 9
No matching records found